ClinicalTrials.Veeva

Menu

The Effect of Flexitarian, Time-restricted Eating on Cardiometabolic Traits in Normal Weight, Young Men (FlexiFast)

U

University of Warmia and Mazury in Olsztyn

Status

Active, not recruiting

Conditions

Lipid Metabolism Disorders
Glucose Metabolism Disorders
Cardiometabolic Syndrome
Blood Pressure

Treatments

Behavioral: Dietary

Study type

Interventional

Funder types

Other

Identifiers

NCT05762263
2021/41/N/NZ9/01129

Details and patient eligibility

About

The goal of this factorial randomized controlled trial is to find out whether time-restricted eating and flexitarian diet (on its own and combined) can improve cardiometabolic health markers in normal weight, young men with metabolic abnormalities?

Participants will be assigned to four groups: control, flexitarian, time-restricted eating and time-restricted eating + flexitarian. Investigators will look for men with elevated fasting blood glucose or blood lipids level or blood pressure and with normal body weight and waistline. Participants from the flexitarian group will be asked to follow a diet that has been carefully designed for them by the PI and dietitian for the period of 8 weeks. Participants from the control group will receive general healthy eating recommendations.

We aim to investigate if the experiment had any effect on changes in metabolic, inflammation and nutritional markers, blood pressure and body weight and composition. Also, the effect of diets on men's sleep, general wellbeing and satisfaction with treatment will be investigated.

The proposed study can test a potentially effective nutritional intervention which is feasible to adopt and sustainable (in line with recent planetary diet recommendations). Confirming its effectiveness can fill the research gap, providing new knowledge and approach to the prevention and treatment of metabolic abnormalities in young, lean men.

Enrollment

96 estimated patients

Sex

Male

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Males
  • Age 18-40 years
  • Normal body weight
  • At least one of metabolic abnormalities (elevated fasting glucose level - but not diabetes, elevated blood lipids, elevated blood pressure)

Exclusion criteria

  • Females
  • Age <18 and >40 years
  • Overweight or obesity (BMI>25 kg/m2)
  • WC > 94cm
  • Alcohol >14 units/week
  • Smoking
  • On medication
  • Diabetes or other chronic diseases
  • Vegetarians or vegans
  • Don't own or unable to use a Smartphone with Apple iOS or Android OS

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

96 participants in 4 patient groups

Control group
No Intervention group
Description:
Habitual diet - healthy eating guidelines provided for ethical reasons, no restrictions on the time of eating
Flexitarian diet group
Experimental group
Description:
Flexitarian diet (FD) will be based on planetary diet recommendations (predominantly plants; pulses and legumes as protein sources, meat and poultry consumed occasionally). Ways to facilitate this diet will be presented in the booklet prepared for them by the PI and a dietitian.
Treatment:
Behavioral: Dietary
Time-restricted eating group
Experimental group
Description:
Time restricted eating (TRE) with 6 hour eating window - start and end hour to be an individual choice (some may prefer to consume their meals within an early window, e.g. 10am-4pm, some may prefer to consume their meals later in the day, e.g. 12:00-6pm). However, participants will be asked to be fairly consistent with their choice of their timing of eating hours. During fasting only water will be permitted;
Treatment:
Behavioral: Dietary
Flexitarian diet & time-restricted eating group
Experimental group
Description:
Treatment TRE and FD combined.
Treatment:
Behavioral: Dietary

Trial contacts and locations

1

Loading...

Central trial contact

Marta Lonnie, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems